Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacopo Angelini

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 6, 2022
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?Rossana Roncato, Jacopo Angelini, Arianna Pani, et al.
European Cardiology|June 25, 2025
Oral P2Y<sub>12</sub> Inhibitors: Victims or Perpetrators? A Focused Review on Pharmacokinetic, Clinically Relevant Drug InteractionsElisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli, et al.
Frontiers in Bioscience (Landmark Edition)|November 6, 2025
Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative DrugsGiulia Zudeh, Sara Sossai, Jacopo Angelini, et al.
International Journal of Molecular Sciences|April 30, 2021
The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis PatientsJacopo Angelini, Davide Marangon, Stefano Raffaele, et al.
Clinical Microbiology Reviews|March 13, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenariosJacopo Angelini, Sara Ferin, Luca Martini, et al.
Microorganisms|December 23, 2023
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal InfectionsPier Giorgio Cojutti, Simone Giuliano, Renato Pascale, et al.
Journal of Fungi (Basel, Switzerland)|July 26, 2024
Phenotypical Differences at the Physiological and Clinical Level between Two Genetically Closely Related <i>Clavispora lusitaniae</i> Strains Isolated from PatientsDebora Casagrande Pierantoni, Simone Giuliano, Angela Conti, et al.
Pharmaceutics|September 28, 2023
Meropenem PK/PD Variability and Renal Function: "We Go Together"Jacopo Angelini, Simone Giuliano, Sarah Flammini, et al.
Pharmacotherapy|August 7, 2025
Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample StrategiesSimone Giuliano, Manjunath P Pai, Jacopo Angelini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2026
A Comparative Evaluation of Aztreonam-Avibactam and Ceftazidime-Avibactam Plus Aztreonam for Infections Due to MBL-Producing EnterobacteralesSimone Giuliano, Chiara Moreal, Jacopo Angelini, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 6, 2022
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?Rossana Roncato, Jacopo Angelini, Arianna Pani, et al.
European Cardiology|June 25, 2025
Oral P2Y<sub>12</sub> Inhibitors: Victims or Perpetrators? A Focused Review on Pharmacokinetic, Clinically Relevant Drug InteractionsElisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli, et al.
Frontiers in Bioscience (Landmark Edition)|November 6, 2025
Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative DrugsGiulia Zudeh, Sara Sossai, Jacopo Angelini, et al.
International Journal of Molecular Sciences|April 30, 2021
The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis PatientsJacopo Angelini, Davide Marangon, Stefano Raffaele, et al.
Clinical Microbiology Reviews|March 13, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenariosJacopo Angelini, Sara Ferin, Luca Martini, et al.
Microorganisms|December 23, 2023
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal InfectionsPier Giorgio Cojutti, Simone Giuliano, Renato Pascale, et al.
Journal of Fungi (Basel, Switzerland)|July 26, 2024
Phenotypical Differences at the Physiological and Clinical Level between Two Genetically Closely Related <i>Clavispora lusitaniae</i> Strains Isolated from PatientsDebora Casagrande Pierantoni, Simone Giuliano, Angela Conti, et al.
Pharmaceutics|September 28, 2023
Meropenem PK/PD Variability and Renal Function: "We Go Together"Jacopo Angelini, Simone Giuliano, Sarah Flammini, et al.
Pharmacotherapy|August 7, 2025
Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample StrategiesSimone Giuliano, Manjunath P Pai, Jacopo Angelini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2026
A Comparative Evaluation of Aztreonam-Avibactam and Ceftazidime-Avibactam Plus Aztreonam for Infections Due to MBL-Producing EnterobacteralesSimone Giuliano, Chiara Moreal, Jacopo Angelini, et al.
Pageof 3